Search Results - "Granot, Noa"

History of hematopoietic cell transplantation: challenges and progress by Granot, Noa, Storb, Rainer

“…After more than 60 years of research in allogeneic hematopoietic cell transplantation (HCT), this therapy has advanced from one that was declared dead in the…”
Get full text

“The Course of Love Never Did Run Smooth”: Ex-Inmates’ Attitudes Toward Heterosexual Romantic Relationships by Granot, Noa, Einat, Tomer

“…This study examines the attitudes of 15 male ex-inmates toward heterosexual romantic relationships during imprisonment as viewed retrospectively. The…”
Get full text

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades by Cooper, Jason P, Storer, Barry E, Granot, Noa, Gyurkocza, Boglark, Sorror, Mohamed L, Chauncey, Thomas R, Shizuru, Judith, Franke, Georg-Nikolaus, Maris, Michael B, Boyer, Michael, Bruno, Benedetto, Sahebi, Firoozeh, Langston, Amelia A, Hari, Parameswaran, Agura, Edward D, Lykke Petersen, Søren, Maziarz, Richard T, Bethge, Wolfgang, Asch, Julie, Gutman, Jonathan A, Olesen, Gitte, Yeager, Andrew M, Hübel, Kai, Hogan, William J, Maloney, David G, Mielcarek, Marco, Martin, Paul J, Flowers, Mary E D, Georges, George E, Woolfrey, Ann E, Deeg, Joachim H, Scott, Bart L, McDonald, George B, Storb, Rainer, Sandmaier, Brenda M

“…We have used a non-myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation for the past twenty years. During that period, changes…”
Get full text

Anti-ICOS mAb Targets Pathogenic IL-17A-expressing Cells in Canine Model of Chronic GVHD by Parker, Maura H., Stone, Diane, Abrams, Kraig, Johnson, Melissa, Granot, Noa, Storb, Rainer

“…BACKGROUND:Chronic graft-versus-host disease (GVHD) is a significant cause of morbidity and mortality in transplant patients. We have previously shown that 3…”
Get full text

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation by Morsink, Linde M, Sandmaier, Brenda M, Othus, Megan, Palmieri, Raffaele, Granot, Noa, Bezerra, Evandro D, Wood, Brent L, Mielcarek, Marco, Schoch, Gary, Davis, Chris, Flowers, Mary E D, Deeg, H Joachim, Appelbaum, Frederick R, Storb, Rainer, Walter, Roland B

“…How conditioning intensity is related to outcomes of AML patients undergoing allografting in morphologic remission is an area of great ongoing interest. We…”
Get full text

Syncytial variant of nodular sclerosing Hodgkin lymphoma in children: A prognostic factor? by Granot, Noa, Ben-Barak, Ayelet, Fisher, Yael, Golan, Hana, Weyl Ben-Arush, Myriam

“…Nodular sclerosing Hodgkin lymphoma (HL) has an excellent prognosis in children. The syncytial variant (SV) of HL in adults represents a clinic pathologic…”
Get full text

20 Years of Experience with Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting by Granot, Noa, Storer, Barry E., Sandmaier, Brenda M., Storb, Rainer

“…Reduced intensity conditioning with fludarabine and low dose total body irradiation before allogeneic hematopoietic stem cell transplantation (HCT) was…”
Get full text

Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting by Granot, Noa, Storer, Barry E., Cooper, Jason P., Flowers, Mary E., Sandmaier, Brenda M., Storb, Rainer

“…•Outpatient allogeneic hematopoietic cell transplantation (HCT) in older or infirm patients is feasible and safe.•Nearly half of the recipients remained…”
Get full text

Impact of Peri-Transplant Rituximab and Host/Donor Fc Receptor Polymorphisms for Patients with Relapsed or Refractory CD20+ B-Cell Malignancies by Granot, Noa, Rezvani, Andrew, Storer, Barry E., Pender, Barbara S., Sandmaier, Brenda M., Storb, Rainer, Maloney, David G.

“…We previously reported results of allogeneic hematopoietic cell transplantation (HCT) in 93 older or medically unfit patients with non-Hodgkin's lymphoma (NHL)…”
Get full text

Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies by Granot, Noa, Rezvani, Andrew R., Pender, Barbara S., Storer, Barry E., Sandmaier, Brenda M., Storb, Rainer, Maloney, David G.

“…•Peritransplantation rituximab was not effective in improving survival.•Rituximab levels of >25 μg/mL were sustained throughout the course of…”
Get full text